New NNRTI MK-1439 shows promise in early clinical trial
Dual CCR5/CCR2 inhibitor cenicriviroc has anti-inflammatory as well as anti-HIV effect
Small risk of neurological birth defects due to efavirenz confirmed in French cohort
HIV treatment for children is safe and highly effective without laboratory monitoring in large African trial
French studies report real-world data on use of telaprevir and boceprevir in people with HIV and hepatitis C co-infection
Participation in community groups increases uptake of HIV testing services in Zimbabwe
Very early antiretroviral treatment limits the size of HIV reservoir
Sofosbuvir/ledipasvir/ribavirin cures 100% of genotype 1 hepatitis C patients
Consistent condom use in anal sex stops 70% of HIV infections, study finds
